- Report Summary
- Table of Contents
- Enquiry Before Buying
Report Summary
The global infectious disease diagnostics market is expected to grow significantly from USD 18.70 Billion in 2018 to USD 26.50 Billion in 2025, at a CAGR of 5.1% from 2019 to 2025. The market growth is attributed to the increasing inclination towards point-of-care testing and growing prevalence of infectious diseases across the globe. Moreover, technological advancements in infectious disease diagnostics and growing demand in emerging countries are further propelling the industry growth.
Bacterial and viral infections are among the leading cause of disease and death. Infectious Diseases Diagnostics is the procedure by which the causative agent an infectious disease is identified. Additionally, new technique used in infectious diseases diagnostics includes nucleic acid-based diagnostics, next-generation sequencing, and peptide nucleic acid fluorescent in situ hybridization (FISH) technologies, among others.
The years used for the assessment are as follows:
Historical year: 2015, 2016, 2017
Base year: 2018
Forecast period: 2019 – 2025
RESEARCH METHODOLOGY
The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;
- Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
- Interacting with key opinion leaders of the market and developing data points based on interaction with them
- Study of past trends in the market and their year on year Impact on the market size and share
- Analyzing the collected data points
- Bridging the data points to calculate the total global infectious disease diagnostic market and its various segments
- Anticipating potential risks
- Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global infectious disease diagnostic market
- Finalizing the overall size and share of the global infectious disease diagnostic market
OBJECTIVES:
- To classify the global coronary stent market into segments and analyze their growth prospects individually.
- To analyze market trends, opportunities, drivers and restraints associated with the infectious disease diagnostics market.
- Profiling key companies operating in the global infectious disease diagnostic market
- To study market response with respect to the mergers and acquisitions in the industry
Table of Contents
TABLE OF CONTENTS
CHAPTER 1. Market Scope and Methodology
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
CHAPTER 2. Executive Summary
2.1. Global Infectious Diseases Diagnostics- Market Snapshot
CHAPTER 3. Industry Analysis
3.1. Market Definition
3.2. Market Segmentation
3.3. Key Findings of The Global Infectious Diseases Diagnostics Market
3.4. Value Chain Analysis
3.5. Market Opportunities & Trends
3.5.1. Increasing investments by major key players
3.5.2. Growing demand in emerging countries
3.6. Market dynamics
3.6.1. Market driver analysis
3.6.1.1. Growing prevalence of infectious diseases across the globe
3.6.1.2. Increasing inclination towards point-of-care testing
3.6.1.3. Technological advancements in infectious disease diagnostics
3.6.2. Market restraint analysis
3.6.2.1. Rising healthcare costs
3.6.2.2. Stringent government regulation
CHAPTER 4. Competitive Outlook
4.1. Company Market Share Analysis
4.2. Porters Five Forces Analysis
CHAPTER 5. Global Infectious Diseases Diagnostics Market Size and Forecast (2015 – 2025)
5.1. Global Infectious Diseases Diagnostics Market, By Product and Service (USD Billion)
5.1.1. Services and Software
5.1.2. Instruments
5.1.3. Consumables
5.2. Global Infectious Diseases Diagnostics Market, By Application (USD Billion)
5.2.1. Viral Infection
5.2.2. GI infections
5.2.3. Bacterial Infection
5.2.4. Sexually Transmitted Disease
5.2.5. CNS Infections
5.2.6. Fungal infection
5.2.7. Cardiovascular infection
5.2.8. Others
5.3. Global Infectious Diseases Diagnostics Market, By Technology (USD Billion)
5.3.1. Polymerase Chain Reaction (PCR)
5.3.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
5.3.3. Immunodiagnostics
5.3.4. DNA Microarray
5.3.5. Clinical Microbiology
5.3.6. DNA Sequencing & Next-Generation Sequencing (NGS)
5.3.7. Others
5.4. Global Infectious Diseases Diagnostics Market, By End-User (USD Billion)
5.4.1. Research Institutes
5.4.2. Diagnostic Clinics
5.4.3. Hospital Laboratories
5.4.4. Ambulatory Clinics
5.4.5. Contract Research Organization
CHAPTER 6. Global Infectious Diseases Diagnostics Market, By Geography (2015 – 2025)
6.1. North America Infectious Diseases Diagnostics Market
6.1.1. North America Infectious Diseases Diagnostics Market, By Product and Service (USD Billion)
6.1.2. North America Infectious Diseases Diagnostics Market, By Application (USD Billion)
6.1.3. North America Infectious Diseases Diagnostics Market, By Technology (USD Billion)
6.1.4. North America Infectious Diseases Diagnostics Market, By End-User (USD Billion)
6.1.5. North America Infectious Diseases Diagnostics Market, By Country
6.1.5.1. The United States
6.1.5.2. Canada
6.1.5.3. Mexico
6.2. Europe Infectious Diseases Diagnostics Market
6.2.1. Europe Infectious Diseases Diagnostics Market, By Product and Service (USD Billion)
6.2.2. Europe Infectious Diseases Diagnostics Market, By Application(USD Billion)
6.2.3. Europe Infectious Diseases Diagnostics Market, By Technology (USD Billion)
6.2.4. Europe Infectious Diseases Diagnostics Market, By End-User (USD Billion)
6.2.5. Europe Infectious Diseases Diagnostics Market, By Country
6.2.5.1. France
6.2.5.2. U.K
6.2.5.3. Italy
6.2.5.4. Russia
6.2.5.5. Spain
6.2.5.6. Germany
6.2.5.7. Rest of Europe
6.3. Asia-Pacific Infectious Diseases Diagnostics Market
6.3.1. Asia-Pacific Infectious Diseases Diagnostics Market, By Product and Service (USD Billion)
6.3.2. Asia-Pacific Infectious Diseases Diagnostics Market, By Application (USD Billion)
6.3.3. Asia-Pacific Infectious Diseases Diagnostics Market, By Technology (USD Billion)
6.3.4. Asia-Pacific Infectious Diseases Diagnostics Market, By End-User (USD Billion)
6.3.5. Asia-Pacific Infectious Diseases Diagnostics Market, By Country
6.3.5.1. Australia
6.3.5.2. China
6.3.5.3. Indonesia
6.3.5.4. India
6.3.5.5. Singapore
6.3.5.6. Malaysia
6.3.5.7. Japan
6.3.5.8. Rest of Asia-Pacific
6.4. Central & South America Infectious Diseases Diagnostics Market
6.4.1. Central & South America Infectious Diseases Diagnostics Market, By Product and Service (USD Billion)
6.4.2. Central & South America Infectious Diseases Diagnostics Market, By Application (USD Billion)
6.4.3. Central & South America Infectious Diseases Diagnostics Market, By Technology (USD Billion)
6.4.4. Central & South America Infectious Diseases Diagnostics Market, By End-User (USD Billion)
6.4.5. Central & South America Infectious Diseases Diagnostics Market, By Country
6.4.5.1. Argentina
6.4.5.2. Brazil
6.4.5.3. Rest of Central & South America
6.5. Middle East and Africa Infectious Diseases Diagnostics Market
6.5.1. Middle East and Africa Infectious Diseases Diagnostics Market, By Product and Service (USD Billion)
6.5.2. Middle East and Africa Infectious Diseases Diagnostics Market, By Application (USD Billion)
6.5.3. Middle East and Africa Infectious Diseases Diagnostics Market, By Technology (USD Billion)
6.5.4. Middle East and Africa Infectious Diseases Diagnostics Market, By End-User (USD Billion)
6.5.5. Middle East and Africa Infectious Diseases Diagnostics Market, By Country
6.5.5.1. Saudi Arabia
6.5.5.2. South Africa
6.5.5.3. Rest of Middle East and Africa
CHAPTER 7. Key Players and Strategic Developments
7.1. F. Hoffmann-La Roche Ltd
7.1.1. Business Overview
7.1.2. Product and Service Offering
7.1.3. Financial Overview
7.1.4. Strategic Developments
7.2. Cepheid
7.2.1. Business Overview
7.2.2. Product and Service Offering
7.2.3. Financial Overview
7.2.4. Strategic Developments
7.3. bioMérieux SA
7.3.1. Business Overview
7.3.2. Product and Service Offering
7.3.3. Financial Overview
7.3.4. Strategic Developments
7.4. Boston Scientific Corporation
7.4.1. Business Overview
7.4.2. Product and Service Offering
7.4.3. Financial Overview
7.4.4. Strategic Developments
7.5. Abbott Laboratories
7.5.1. Business Overview
7.5.2. Product and Service Offering
7.5.3. Financial Overview
7.5.4. Strategic Developments
7.6. Bio-Rad Laboratories, Inc.
7.6.1. Business Overview
7.6.2. Product and Service Offering
7.6.3. Financial Overview
7.6.4. Strategic Developments
7.7. Thermo Fisher Scientific, Inc.
7.7.1. Business Overview
7.7.2. Product and Service Offering
7.7.3. Financial Overview
7.7.4. Strategic Developments
7.8. Hologic, Inc.
7.8.1. Business Overview
7.8.2. Product and Service Offering
7.8.3. Financial Overview
7.8.4. Strategic Developments
Enquiry Before Buying
Global Infectious Disease Diagnostic Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation and Forecast 2025
Related Reports
-
Global Smart Contact Lenses Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 18, 2019 -
Global Mobile Cardiac Telemetry (MCT) Devices Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 14, 2019 -
Global Companion Diagnostics Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 10, 2019 -
Global Coronary Stent Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025
May 8, 2019
The post Global Infectious Disease Diagnostic Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2025 appeared first on Energias Market Research.
This post first appeared on Market Research Reports, Market Analysis, Market Survey, please read the originial post: here
